Advertisement

Minimal-invasive Chirurgie des Uterus myomatosus

Möglichkeiten und Risiken
  • Admir AgicEmail author
  • Wolfgang Küpker
Leitthema
  • 19 Downloads

Zusammenfassung

Leiomyome des Uterus oder der Uterus myomatosus zählen zu den häufigsten Erkrankungen der Frau. Die Myomenukleation oder die Hysterektomie bei Uterus myomatosus gehören nach wie vor zu den am häufigsten durchgeführten Standardprozeduren im gynäkologischen Alltag. Mit dem Siegeszug der minimal-invasiven Techniken in das Standardrepertoire des Gynäkologen ergeben sich mehrere Optionen einer gezielten Therapie. Die moderne, differenzierte operative Therapie ist eine wichtige Säule unter den verschiedenen Behandlungsmöglichkeiten bei Uterus myomatosus.

Schlüsselwörter

Myomektomie Leiomyom Hysterektomie Hämorrhagie Morcellierung 

Minimally invasive surgery for uterine fibroids

Possibilities and risks

Abstract

Uterine fibroids or uterine leiomyomas are one of the most common diseases in women with almost every second woman suffering from this pathology. Consecutive myomectomy and hysterectomy are standard procedures for a gynecologist. With modern technologies using high-end minimally invasive surgical interventions, there are several options available for individualized tailored treatment.

Keywords

Myomectomy Leiomyoma Hysterectomy Hemorrhage Morcellation 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

A. Agic und W. Küpker geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Boosz AS, Reimer P, Matzko M, Römer T, Müller A (2014) Konservative, operative und interventionelle Therapieoptionen uteriner Myome. Dtsch Arztebl Int 111(51–52):877PubMedPubMedCentralGoogle Scholar
  2. 2.
    Metwally M, Cheong YC, Horne AW (2012) Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD003857.pub3 CrossRefPubMedGoogle Scholar
  3. 3.
    Jin C, Hu Y, Chen XC et al (2009) Laparoscopic versus open myomectomy—a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 145:14–21CrossRefGoogle Scholar
  4. 4.
    Falcone T, Parker WH (2013) Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol 121:856–868CrossRefGoogle Scholar
  5. 5.
    Ribeiro SC, Reich H, Rosenberg J, Guglielminetti E, Vidali A (1999) Laparoscopic myomectomy and pregnancy outcome in infertile patients. Fertil Steril 71:571–574CrossRefGoogle Scholar
  6. 6.
    Campo R, Belle Y, Rombauts L, Brosens I, Gordts S (1999) Office mini-hysteroscopy. Hum Reprod Update 5(1):73–81CrossRefGoogle Scholar
  7. 7.
    Jansen FW, Vredevoogd CB, Ulzen K, Hermans J, Trimbos JB, Trimbos-Kemper TC (2000) Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol Clin North Am 96(2):266–270Google Scholar
  8. 8.
    Taylor E, Gomel V (2008) The uterus and fertility. Fertil Steril 89(1):1–15CrossRefGoogle Scholar
  9. 9.
    Pritts EA (2001) Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv 56(8):483–491CrossRefGoogle Scholar
  10. 10.
    Pritts EA, Parker WH, Olive DL (2009) Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 91:1215–1223CrossRefGoogle Scholar
  11. 11.
    Malik E, Diedrich K (2002) Gynäkologische Endoskopie pro und kontra. Steinkopff, Darmstadt, S 59–61Google Scholar
  12. 12.
    Kongnyuy EJ, Wiysonge CS (2011) Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD005355.pub4 CrossRefPubMedGoogle Scholar
  13. 13.
    Ginsburg ES, Benson CB, Garfield JM, Gleason RE, Friedman AJ (1993) The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. Fertil Steril 60:956–962CrossRefGoogle Scholar
  14. 14.
    Fletcher H, Frederick J, Hardie M, Simeon D (1996) A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol 87:1014–1018CrossRefGoogle Scholar
  15. 15.
    Riess ML, Ulrichs JG, Pagel PS, Woehlck HJ (2011) Case report: severe vasospasm mimics hypotension after high-dose intrauterine vasopressin. Anesth Analg 113:1103–1105CrossRefGoogle Scholar
  16. 16.
    Sentilhes L, Vayssière C, Beucher G et al (2013) Delivery for women with a previous cesarean: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol 170:25–32CrossRefGoogle Scholar
  17. 17.
    Miller DA, Goodwin TM, Gherman RB, Paul RH (1997) Intrapartum rupture of the unscarred uterus. Obstet Gynecol 89:671–673CrossRefGoogle Scholar
  18. 18.
    Kim MS, Uhm YK, Kim JY, Jee BC, Kim YB (2013) Obstetric outcomes after uterine myomectomy: laparoscopic versus laparotomic approach. Obstet Gynecol Sci 56:375–381CrossRefGoogle Scholar
  19. 19.
    Bernardi TS, Radosa MP, Weisheit A et al (2014) Laparoscopic myomectomy: a 6-year follow-up single-center cohort analysis of fertility and obstetric outcome measures. Arch Gynecol Obstet 290:87–91CrossRefGoogle Scholar
  20. 20.
    Stotland NE, Lipschitz LS, Caughey AS (2002) Delivery strategies for women with a previous classic cesarean delivery: adecision analysis. Am J Obstet Gynecol 187:1203–1208CrossRefGoogle Scholar
  21. 21.
    Fukuda M, Tanaka T, Kamada M et al (2013) Comparison of the perinatal outcomes after laparoscopic myomectomy versus abdominal myomectomy. Gynecol Obstet Invest 76:203–208CrossRefGoogle Scholar
  22. 22.
    Koivisto-Korander R, Martinsen JI, Weiderpass E, Leminen A, Pukkala E (2012) Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases. Maturitas 72(1):56–60CrossRefGoogle Scholar
  23. 23.
    Lethaby A, Mukhopadhyay A, Naik R (2012) Total versus subtotal hysterectomy for benign gynaecological conditions. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD004993.pub3 CrossRefPubMedGoogle Scholar
  24. 24.
    Boosz A, Lermann J, Mehlhorn G et al (2011) Comparison of re-operation rates and complication rates after total laparoscopic hysterectomy (TLH) and laparoscopy-assisted supracervical hysterectomy (LASH). Eur J Obstet Gynecol Reprod Biol 158:269–273CrossRefGoogle Scholar
  25. 25.
    Beckmann MW et al (2015) Exstirpierende Verfahren zur Behandlung von Uterusmyomen – Uterussarkomrisiko und Problematik der Morcellation: Positionspapier der DGGG. Geburtshilfe Frauenheilkd 75:1–17CrossRefGoogle Scholar
  26. 26.
    DGGG S3-Leitlinie – Indikation und Methodik der Hysterektomie bei benignen Erkrankungen. Stand: 31.12.2014, gültig bis 30.12.2019. AWMF Registernummer: 015/070, Leitlinienklasse S3, Stand April 2015, Version 1.2. http://www.awmf.org/leitlinien/detail/ll/015-070.html Google Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.FrauenklinikRKH Krankenhaus MühlackerMühlackerDeutschland
  2. 2.Frauenklinik Baden-Baden BühlKlinikum MittelbadenBühlDeutschland

Personalised recommendations